Cargando…
M2e-Based Universal Influenza A Vaccines
The successful isolation of a human influenza virus in 1933 was soon followed by the first attempts to develop an influenza vaccine. Nowadays, vaccination is still the most effective method to prevent human influenza disease. However, licensed influenza vaccines offer protection against antigenicall...
Autores principales: | Deng, Lei, Cho, Ki Joon, Fiers, Walter, Saelens, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494237/ https://www.ncbi.nlm.nih.gov/pubmed/26344949 http://dx.doi.org/10.3390/vaccines3010105 |
Ejemplares similares
-
Immunogenicity of Live Attenuated B. pertussis BPZE1 Producing the Universal Influenza Vaccine Candidate M2e
por: Kammoun, Hana, et al.
Publicado: (2013) -
Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages
por: Deng, Lei, et al.
Publicado: (2015) -
Controlling Influenza by Cytotoxic T-Cells: Calling for Help from Destroyers
por: Schotsaert, Michael, et al.
Publicado: (2010) -
Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies
por: Schotsaert, Michael, et al.
Publicado: (2016) -
The Role of Matrix Protein 2 Ectodomain in the Development of Universal Influenza Vaccines
por: Saelens, Xavier
Publicado: (2019)